Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Articles, guides, and regulatory updates from our community.
New research explores antimicrobial peptide nanoparticles activated by near-infrared light to combat biofilm infections in diabetic wounds. Learn what the study found.
By Peptide Association Research Team
A landmark 2026 BMJ network meta-analysis of 262 trials compares 19 obesity drugs. See what researchers found about weight loss, harms, and cardiovascular outcomes.
By Peptide Association Research Team
New research shows continuous spin-freeze-drying of PEGylated peptides can scale to GMP manufacturing while maintaining product quality and stability.
By Peptide Association Research Team
New research explores continuous spin-freeze-drying scale-out for PEGylated peptides, showing consistent quality from lab to GMP production. Learn what this means.
By Peptide Association Research Team
New research suggests a biomimetic hematoma scaffold may enable ultra-low-dose BMP-2 to outperform standard bone repair methods. Learn what the study found.
By Peptide Association Research Team
A 2026 clinical study suggests HMB supplementation may support immune response and intracellular protein synthesis in critically ill ICU patients. Learn what researchers found.
By Peptide Association Research Team
New research shows continuous spin-freeze-drying can scale from lab to GMP manufacturing while preserving peptide quality. Learn what this means for patients.
By Peptide Association Research Team
New research explores scalable freeze-drying for PEGylated peptide formulations. Learn what this manufacturing breakthrough may mean for peptide therapy access.
By Peptide Association Research Team
New research reveals how telehealth rules, NP authority, and compounding infrastructure create major geographic gaps in peptide-based sexual medicine access.
By Peptide Association Research Team
A major 2026 BMJ network meta-analysis compared 19 obesity drugs across 262 trials. See what the evidence shows about benefits, harms, and trade-offs.
By Peptide Association Research Team
New research explores how DNA methylation and the Wnt signaling pathway may influence Alzheimer's disease progression linked to insulin resistance.
By Peptide Association Research Team
A 2026 study reveals significant geographic disparities in access to peptide-based sexual medicine therapies driven by state-level healthcare policies.
By Peptide Association Research Team
A major 2025 BMJ network meta-analysis compared 19 obesity drugs across 262 trials. See what researchers found about benefits, risks, and tradeoffs.
By Peptide Association Research Team
New research finds where you live—not just federal policy—may determine your access to peptide-based sexual medicine therapies. Here's what the data shows.
By Peptide Association Research Team
A major 2025 BMJ network meta-analysis of 262 trials compares 19 obesity drugs on weight loss, safety, and cardiovascular outcomes. Here's what patients should know.
By Peptide Association Research Team
A 2026 NIDDK workshop study examines how real-world evidence can fill critical gaps in GLP-1 receptor agonist safety, effectiveness, and coverage decisions.
By Peptide Association Research Team
New 2026 research reveals wide geographic disparities in access to peptide-based sexual medicine therapies driven by state telehealth, NP, and compounding laws.
By Peptide Association Research Team
New research suggests a biomimetic hematoma scaffold may enable ultra-low-dose BMP-2 to outperform standard collagen sponge delivery in large bone defect repair.
By Peptide Association Research Team
A 2026 clinical study suggests HMB supplementation may support immune response and intracellular amino acid synthesis in critically ill ICU patients.
By Peptide Association Research Team
New research explores how IL-15 and Thymosin α1 may reduce immune aging in hepatocellular carcinoma. Learn what the findings mean for future cancer therapy.
By Peptide Association Research Team
New research suggests elamipretide (SS-31) may support recovery after spinal cord injury by preserving mitochondrial function and reducing cell death in animal models.
By Peptide Association Research Team
A 2026 critical review examines peptide use in competitive and recreational sport, highlighting limited clinical evidence and emerging health risks. Read the findings.
By Peptide Association Research Team
New research explores how copper peptide GHK-Cu combined with glucose oxidase may support diabetic wound healing through cascade catalysis. Learn what the study found.
By Peptide Association Research Team
New research explores how IL-15 and Thymosin α1 may reduce immune cell aging in hepatocellular carcinoma. Learn what the findings mean for patients.
By Peptide Association Research Team